Lista de obras - Ettore Seregni - Dominio Público Uruguay

(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.

artículo científico publicado en 2009

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas

artículo científico publicado en 2005

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.

artículo científico publicado en 2018

A female survivor of childhood medulloblastoma presenting with growth-hormone-induced edema and inflammatory lesions: a case report

artículo científico publicado en 2009

A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer.

artículo científico publicado en 2013

Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).

artículo científico publicado en 2009

An improved automated one-pot synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) based on a purification by cartridges

artículo científico publicado en 2019

Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle

scientific article published on 23 July 2019

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

artículo científico publicado en 1998

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

artículo científico publicado en 2002

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases

artículo científico publicado en 1992

Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?

scientific article published on 01 November 1997

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

scientific article published on 06 December 2006

Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence

scientific article published on 01 March 2006

DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.

artículo científico publicado en 2013

Diagnostic and prognostic tumor markers in the gastrointestinal tract.

artículo científico publicado en 2001

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

artículo científico publicado en 2007

Effect of 10-day broccoli consumption on inflammatory status of young healthy smokers

artículo científico publicado en 2013

Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen

artículo científico publicado en 2015

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

artículo científico publicado en 2002

Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge.

artículo científico publicado en 2018

Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC)

scientific article published on 01 January 1996

Evidence of oncogene-induced senescence in thyroid carcinogenesis.

artículo científico publicado en 2011

Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours

artículo científico publicado en 2004

Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging

artículo científico publicado en 2016

Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.

artículo científico publicado en 2011

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

artículo científico publicado en 2008

Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape

artículo científico publicado en 2005

Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.

artículo científico

Impressive Response to Tandem Treatment With [90Y]DOTATOC and [177Lu]DOTATOC in Grade 3 Pancreatic Neuroendocrine Carcinoma

artículo científico publicado en 2018

Incident pain and analgesic consumption decrease after samarium infusion: a pilot study

artículo científico publicado en 2006

Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry

artículo científico publicado en 2005

Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas

artículo científico publicado en 2010

Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?

artículo científico publicado en 2012

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

scientific article published on 04 May 2018

Lifestyle and breast cancer recurrences: the DIANA-5 trial

artículo científico publicado en 2012

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

artículo científico publicado en 2013

Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.

artículo científico publicado en 2012

Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns

artículo científico publicado en 2016

Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel

artículo científico publicado en 2017

Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group

scientific article published on 26 March 2019

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

artículo científico publicado en 2010

Neuron-specific enolase evaluation in patients with neuroblastoma.

artículo científico publicado en 1998

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

artículo científico publicado en 2004

P53 Accumulation in Primary Breast Cancer: A Comparison between Immunohistochemistry and a Novel Luminometric Immunoassay

artículo científico publicado en 1998

Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the Istituto Nazionale Tumori in Milan

artículo científico publicado en 2006

Pathological diagnosis and tumor markers.

artículo científico publicado en 2010

Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.

artículo científico publicado en 2016

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

artículo científico publicado en 2017

Post-Synthesis Incorporation of ⁶⁴Cu in CuS Nanocrystals to Radiolabel Photothermal Probes: A Feasible Approach for Clinics.

artículo científico publicado en 2015

Preliminary-results of preoperative axillary radioimmunoscintigraphy with in-111 b72.3 in breast-cancer

artículo científico publicado en 1995

Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.

artículo científico publicado en 2015

Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

artículo científico publicado en 2007

Radiation-induced thyroid changes: A retrospective and a prospective view

article

Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.

artículo científico

Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody ⬇️

artículo científico publicado el 1 de enero de 1991

Radioiodine Therapy of Differentiated Thyroid Cancer

Radioisotopic imaging of neuroendocrine tumours. Which radiopharmaceutical and which diagnostic procedure?

artículo científico publicado en 2001

Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results

artículo científico publicado en 1998

Safety and Efficacy of Combined Peptide Receptor Radionuclide Therapy and Liver Selective Internal Radiation Therapy in a Patient With Metastatic Neuroendocrine Tumor

scientific article published on 01 April 2019

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

artículo científico publicado en 1992

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

artículo científico publicado en 2002

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer

artículo científico publicado en 1995

Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy

scientific article published on 01 January 1995

TSH suppression as a possible means of protection against hypothyroidism after irradiation for childhood Hodgkins lymphoma

The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels

artículo científico publicado en 1997

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients

artículo científico publicado en 2004

The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers

artículo científico publicado en 2000

Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper

artículo científico publicado en 2014

Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy?

scientific article published on 01 January 2007

Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor

artículo científico publicado en 2007

Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy

artículo científico publicado en 2014

Tumour marker evaluation in patients with lung cancer ⬇️

artículo científico publicado el 1 de enero de 1995

Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunities

artículo científico publicado en 2013

[Radiometabolic therapy for metastatic thyroid carcinoma: overview of the literature and rational bases for the use of recombinant human TSH]

artículo científico publicado en 2012

c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients

artículo científico publicado en 2002

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.

artículo científico

Lista de obras de Ettore Seregni

(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.

A female survivor of childhood medulloblastoma presenting with growth-hormone-induced edema and inflammatory lesions: a case report

A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer.

Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).

An improved automated one-pot synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) based on a purification by cartridges

Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases

Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence

DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.

Diagnostic and prognostic tumor markers in the gastrointestinal tract.

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

Effect of 10-day broccoli consumption on inflammatory status of young healthy smokers

Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge.

Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC)

Evidence of oncogene-induced senescence in thyroid carcinogenesis.

Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours

Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging

Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape

Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.

Impressive Response to Tandem Treatment With [90Y]DOTATOC and [177Lu]DOTATOC in Grade 3 Pancreatic Neuroendocrine Carcinoma

Incident pain and analgesic consumption decrease after samarium infusion: a pilot study

Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry

Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas

Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

Lifestyle and breast cancer recurrences: the DIANA-5 trial

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.

Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns

Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel

Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

Neuron-specific enolase evaluation in patients with neuroblastoma.

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

P53 Accumulation in Primary Breast Cancer: A Comparison between Immunohistochemistry and a Novel Luminometric Immunoassay

Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the Istituto Nazionale Tumori in Milan

Pathological diagnosis and tumor markers.

Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

Post-Synthesis Incorporation of ⁶⁴Cu in CuS Nanocrystals to Radiolabel Photothermal Probes: A Feasible Approach for Clinics.

Preliminary-results of preoperative axillary radioimmunoscintigraphy with in-111 b72.3 in breast-cancer

Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.

Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Radiation-induced thyroid changes: A retrospective and a prospective view

Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.

Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody ⬇️

Radioiodine Therapy of Differentiated Thyroid Cancer

Radioisotopic imaging of neuroendocrine tumours. Which radiopharmaceutical and which diagnostic procedure?

Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results

Safety and Efficacy of Combined Peptide Receptor Radionuclide Therapy and Liver Selective Internal Radiation Therapy in a Patient With Metastatic Neuroendocrine Tumor

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer

Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy

TSH suppression as a possible means of protection against hypothyroidism after irradiation for childhood Hodgkins lymphoma

The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients

The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers

Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper

Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy?

Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor

Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy

Tumour marker evaluation in patients with lung cancer ⬇️

Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunities

[Radiometabolic therapy for metastatic thyroid carcinoma: overview of the literature and rational bases for the use of recombinant human TSH]

c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients

miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.